↓ Skip to main content

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Overview of attention for article published in Annals of the Rheumatic Diseases, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Citations

dimensions_citation
213 Dimensions

Readers on

mendeley
245 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
Published in
Annals of the Rheumatic Diseases, March 2015
DOI 10.1136/annrheumdis-2014-206404
Pubmed ID
Authors

Rachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, Thomas Hauser, Raashid Luqmani, Matthew D Morgan, Chen Au Peh, Caroline O Savage, Marten Segelmark, Vladimir Tesar, Pieter van Paassen, Michael Walsh, Kerstin Westman, David RW Jayne

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Germany 1 <1%
Canada 1 <1%
Unknown 242 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 44 18%
Other 32 13%
Student > Postgraduate 23 9%
Student > Ph. D. Student 17 7%
Student > Master 17 7%
Other 63 26%
Unknown 49 20%
Readers by discipline Count As %
Medicine and Dentistry 157 64%
Immunology and Microbiology 9 4%
Unspecified 6 2%
Agricultural and Biological Sciences 4 2%
Biochemistry, Genetics and Molecular Biology 3 1%
Other 12 5%
Unknown 54 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#2,704,557
of 25,192,722 outputs
Outputs from Annals of the Rheumatic Diseases
#1,679
of 7,761 outputs
Outputs of similar age
#32,817
of 263,847 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#28
of 77 outputs
Altmetric has tracked 25,192,722 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,761 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.2. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,847 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.